Real-world data (RWD) on tumor response (rwTR) in advanced non-small cell lung cancer (aNSCLC) patients receiving cancer immunotherapy and targeted therapies.

Michael Lu,Natalia Sadetsky,Peter Lambert,Sam Whipple,Michael Dennis Taylor,Todd Riehl,Gregory J. Riely

Real-world data (RWD) on tumor response (rwTR) in advanced non-small cell lung cancer (aNSCLC) patients receiving cancer immunotherapy and targeted therapies.

2018

Michael Lu
Natalia Sadetsky
Peter Lambert
Sam Whipple
Michael Dennis Taylor
Todd Riehl
Gregory J. Riely

6578Background: Overall response rate (ORR) based on Response Evaluation Criteria in Solid Tumors (RECIST) is an established early efficacy endpoint used in clinical trials. Comparison of real worl...

Keywords:

Cancer immunotherapy
Cancer research
Pathology
Lung cancer
Medicine
real world data
tumor response
Clinical trial
Oncology
Response Evaluation Criteria in Solid Tumors
non small cell
Internal medicine
overall response rate

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations